DG
Episodes
3
across 2 shows
First heard
Oct 2026
Guest appearances
2
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
2
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
| Nov 2026 | 2 |
Email alert
Email me when Damian Garda comes up on a podcast
One email a week at most, with the new episodes that mention Damian Garda. Free, no account needed, unsubscribe in one click.
What Damian Garda has said on podcasts
8 statements
Chinese biotech consists of competing firms with diverse strategies and histories.
“the Chinese biotech industry is described as a monolith. But that, of course, is not... how it is. It couldn't be further from the truth. It is rather a bunch of competing firms with differing strategies, differing histories, differing approaches to making medicines for human beings.”
Open the episode · 422: FDA's search for a new leader, and China's largest drugmakersListen at 2:18
China’s biotech and scientific rise is highly important to global health’s future.
“The remarkable ascendance of not just the Chinese biotech industry, but the Chinese scientific apparatus, whether it's in academia or industry, is massively important to everything we cover and to the future of global health.”
Open the episode · 422: FDA's search for a new leader, and China's largest drugmakersListen at 2:57
B1 Medicines ranks first in the China biotech powerhouse index.
“It is B1 Medicines, formerly Baijin, I believe is how it was pronounced, which is an interesting firm in that they were designed to straddle East and West.”
Open the episode · 422: FDA's search for a new leader, and China's largest drugmakersListen at 4:28
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
3 episodes featuring Damian Garda, newest first